LMC Login | CPMC Login | My Games Account Login
Change Region: Asia | Europe | USA | UK | RoW
Register for Updates & Free Games Account
Complete the form below to register with us for updates. We will update you when new challenges and games are available to play.
First Name:
Surname:
Country:
Email:
Re-enter email:
If you would like a free PharmaSchool Games Account so you can record your weekly GCP Challenge Scores please check the box below and add a password:
Free Games Account:
Password:
Re-enter Password:
 
 
 
Weekly GCP Challenge

Answer the questions below and then click the button. The next page will mark your answers and show you how well you have done compared with the previous people who have taken the tests.


Challenge: Orphan Drugs

Question Number 1:

Orphan Drug Status in the USA has a threshold value that is as follows:

The disease or condition for which the drug is intended affects fewer than XXXXXXXX people in the United States or, if the drug is a vaccine, diagnostic drug, or preventive drug, the persons to whom the drug will be administered in the United States are fewer than XXXXXXXX per year.

Above this threshold the Drug may still be classed as Orphan providing that certain criteria are met.

What is the threshold value above?

A
200
B
2,000
C
20,000
D
200,000

Question Number 2:

Which year was the Orphan Drug Act passed in the United States?

A
1973
B
1983
C
1993
D
2003

Question Number 3:

In the USA the Orphan Drug Act is administered by the Office of Orphan Products Development. What is the European Equivalent?

A
OOPD
B
COPD
C
COMP
D
COOD

Question Number 4:

Which of the following completed the European Definition of an orphan medicinal product?

"products intended to be developed for the diagnosis, prevention or treatment of life-threatening or very serious conditions that affect not more than XXX in 10,000 persons in the European Union"

 

A
1
B
5
C
10
D
50

Question Number 5:

Since 1983 in the USA approximately how many products have been brought to market under the Orphan Drug Act?

A
20
B
100
C
200
D
2000

Sort the Challenges
GCP & Guidelines
Trial Design
Adverse Events
Monitoring
Statistics
Abbreviations
General
Show All
Share This With Friends
International Sites: UK Europe Asia Rest of World
PharmaSchool Ltd.
t: +44 (0) 845 224 0891 f: +44 (0) 845 224 0873 e: info@PharmaSchoolUSA.com